Discover the full management transaction log of Ambrx Biopharma Inc., a listed issuer based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). The latest transaction was filed on 19 September 2023 (Acquisition). Among the most active insiders: Cormorant Asset Management, LP. The full history is accessible without an account.
12
Insider Decl.
0
Thresholds
€65m
5 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Buys €65m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.